Changes in Stroke Rehabilitation during the Sars-Cov-2 Shutdown in Switzerland.


Journal

Journal of rehabilitation medicine
ISSN: 1651-2081
Titre abrégé: J Rehabil Med
Pays: Sweden
ID NLM: 101088169

Informations de publication

Date de publication:
01 Mar 2022
Historique:
pubmed: 21 12 2021
medline: 4 3 2022
entrez: 20 12 2021
Statut: epublish

Résumé

Many stroke survivors require continuous outpatient rehabilitation therapy to maintain or improve their neurological functioning, independ-ence, and quality of life. In Switzerland and many other countries, the shutdown to contain SARS-CoV-2 infections led to mobility restrictions and a decrease in therapy delivery. This study investigated the impact of the COVID-19 shutdown on stroke survivors' access to therapy, physical activity, functioning and mood. A prospective observational cohort study in stroke subjects. At 4 time-points (before, during, after the shutdown, and at 3-month follow-up), the amount of therapy, physical activities, motor func-tion, anxiety, and depression were assessed. Thirty-six community-dwelling stroke subjects (median 70 years of age, 10 months post--stroke) were enrolled. Therapy reductions related to the shutdown were reported in 72% of subjects. This decrease was associated with significantly extended sedentary time and minimal deterioration in physical activity during the shutdown. Both parameters improved between reopening and 3-month follow-up. Depressive symptoms increased slightly during the observation period. Patients more frequently report-ed on self-directed training during shutdown. The COVID-19 shutdown had measurable immediate, but no persistent, effects on post--stroke outcomes, except for depression. Importantly, a 2-month reduction in therapy may trigger improvements when therapy is fully re-initiated thereafter.

Identifiants

pubmed: 34927210
doi: 10.2340/jrm.v53.1118
pmc: PMC8902586
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

jrm00272

Références

Lancet. 1991 Jun 22;337(8756):1521-6
pubmed: 1675378
Qual Life Res. 2018 Apr;27(4):999-1014
pubmed: 29350345
Stroke. 1994 Nov;25(11):2220-6
pubmed: 7974549
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Clin Rehabil. 2011 Feb;25(2):146-56
pubmed: 20921029
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
Stroke. 2016 Jun;47(6):e98-e169
pubmed: 27145936
Stroke. 2011 Aug;42(8):2276-9
pubmed: 21680905
J Neurol Phys Ther. 2007 Mar;31(1):3-10
pubmed: 17419883
J Neurol Neurosurg Psychiatry. 2019 May;90(5):498-506
pubmed: 30770457
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Swiss J Econ Stat. 2020;156(1):9
pubmed: 32864360
J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34
pubmed: 7814786
J Am Geriatr Soc. 2006 May;54(5):743-9
pubmed: 16696738
Stroke. 2005 Nov;36(11):2493-6
pubmed: 16224078
Int J Stroke. 2017 Jul;12(5):444-450
pubmed: 28697708
Disabil Health J. 2021 Jan;14(1):101014
pubmed: 33158795
Psychol Med. 2021 Jan 13;:1-10
pubmed: 33436126
Eur J Phys Rehabil Med. 2019 Dec;55(6):695-709
pubmed: 31556508
Int Disabil Stud. 1990 Jan-Mar;12(1):6-9
pubmed: 2211468
Cochrane Database Syst Rev. 2020 Jan 31;1:CD010255
pubmed: 32002991

Auteurs

Jeremia P O Held (JPO)

Vascular Neurology and Neurorehabilitation, Department of Neurology, University Hospital and University Zurich, Zurich, Switzerland. jeremia.held@uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH